BioShares Biotechnology Clinical Trials ETF (BBC) ETF

Expense Ratio: 0.79% | AUM: 42.10M | Issuer: BioShares

BBC Daily Price Range
BBC 52-Week Price Range

BBC - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

BBC has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

BBC - Profile & Info


The investment objective of the Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The clinical trials index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

Issuer BioShares
Expense Ratio 0.79%
Assets Under Management (AUM) 42.10M
Underlying Index BioShares Biotechnology Clinical Trials Index
Asset Class Portfolio-Multi Asset
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $42.10
Options? Yes
Total Holdings 133

BBC - Top Holdings

Symbol Holding Name % of Total
NVAX Novavax Inc 1.92%
WVE WAVE Life Sciences Ltd 1.34%
SRNE Sorrento Therapeutics Inc 1.32%
KURA Kura Oncology Inc 1.29%
RAPT RAPT Therapeutics Inc 1.25%
ATRA Atara Biotherapeutics 1.22%
PRNB Principia Biopharma Inc 1.20%
MRTX Mirati Therapeutics Inc 1.15%
DNLI Denali Therapeutics Inc 1.12%
ITCI Intra-Cellular Therapies Inc 1.11%
RYTM Rhythm Pharmaceuticals Inc 1.10%
XBIT XBiotech Inc 1.10%
AKRO Akero Therapeutics Inc 1.09%
AGEN Agenus Inc 1.06%
XNCR Xencor Inc 1.06%
ARWR Arrowhead Pharmaceutical 1.05%
TGTX TG Therapeutics Inc 1.05%
MGNX MacroGenics Inc 1.04%
CRSP CRISPR Therapeutics AG 1.04%
RIGL Rigel Pharmaceuticals Inc 1.01%
MYOK MyoKardia Inc 1.01%
RCKT Rocket Pharmaceuticals Inc 0.99%
BNTX BioNTech SE 0.99%
TPTX Turning Point Therapeutics Inc 0.99%
MRNS Marinus Pharmaceuticals Inc 0.97%
PTGX Protagonist Therapeutics Inc 0.95%
BBIO Bridgebio Pharma Inc 0.95%
MRSN Mersana Therapeutics Inc 0.94%
CGEN Compugen Ltd 0.93%
OVID Ovid Therapeutics Inc 0.92%
MYOV Myovant Sciences Ltd 0.91%
EDIT EDITAS MEDICIN 0.89%
IOVA Iovance Biotherapeutics Inc 0.89%
FREQ FREQUENCY THERAPEUTICS 0.89%
ZYME ZYMEWORKS INC 0.88%
MIRM Mirum Pharmaceuticals Inc 0.88%
FATE FATE THERAPEUTIC 0.87%
ALLK Allakos Inc 0.86%
CRTX Cortexyme Inc 0.86%
NTLA Intellia Therapeutics Inc 0.86%
FGEN FibroGen Inc. 0.86%
SYRS Syros Pharmaceuticals Inc 0.83%
ARNA Arena Pharmaceuticals 0.83%
SNDX Syndax Pharmaceuticals Inc 0.82%
PRTA Prothena Corp PLC 0.81%
GERN Geron Corp 0.81%
AXSM AXME THERAPUTI 0.81%
MRNA Moderna Inc 0.81%
SWTX Springworks Therapeutics Inc 0.80%
IGMS IGM Biosciences Inc 0.80%
ADAP Adaptimmune Therapeutics Plc 0.79%
EIDX Eidos Therapeutics Inc 0.78%
ATNX Athenex 0.77%
GOSS Gossamer Bio Inc 0.77%
BNY MELLON CASH RESERVE USD 0.76%
CYTK Cytokinetics Inc 0.76%
ASND Ascendis Pharma A/S 0.75%
MGTX MeiraGTx Holdings PLC 0.75%
KRYS Krystal Biotech Inc 0.75%
MDGL Madrigal Pharmaceuticals Inc 0.74%
KZR Kezar Life Sciences Inc 0.74%
CRNX Crinetics Pharmaceuticals Inc 0.74%
BTAI BioXcel Therapeutics Inc 0.74%
APLS Apellis Pharmaceuticals 0.74%
ARQT ARCUTIS BIOTHERAPEUTICS 0.73%
CARA Cara Therapeutics Inc 0.73%
CVM CEL-SCI Corp 0.72%
PRVB Provention Bio Inc 0.72%
KDMN Kadmon Holdings Inc 0.72%
SELB Selecta Biosciences Inc 0.71%
SGMO Sangamo Therapeutics Inc 0.70%
VIR Vir Biotechnology Inc 0.70%
DRNA DICERNA PHARMA 0.70%
BHVN Biohaven Pharmaceutical Holding Co. Ltd. 0.69%
KOD Kodiak Sciences Inc 0.69%
TBIO Translate Bio Inc 0.69%
YMAB Y-mAbs Therapeutics Inc 0.69%
DCPH DCPHRA PHRMCTC 0.69%
DVAX DYNAVAX TECHNO 0.69%
ZIOP ZIOPHARM Oncology Inc 0.68%
IMGN IMMUNOGEN INC 0.68%
ARDX Ardelyx Inc 0.68%
APRE Aprea Therapeutics Inc 0.68%
MEIP MEI Pharma Inc 0.68%
HARP Harpoon Therapeutics Inc 0.68%
XENE Xenon Pharmaceuticals Inc 0.68%
NGM NGM Biopharmaceuticals Inc 0.67%
BCRX BioCryst Pharmaceuticals Inc 0.67%
MTEM Molecular Templates Inc 0.67%
CTMX CytomX Therapeutics Inc 0.67%
KRTX Karuna Therapeutics Inc 0.67%
VKTX Viking Therapeutics Inc 0.65%
VYGR Voyager Therapeutics Inc 0.65%
ALLO Allogene Therapeutics 0.65%
ARVN Arvinas Holding 0.63%
BDTX BLACK DIAMOND THERAPEUTI 0.63%
GTHX G1 Therapeutics Inc 0.63%
ASMB Assembly Biosciences Inc 0.63%
BLUE BLUEBIRD BIO INC 0.62%
ANAB Anaptys Bio Inc 0.62%
RGNX Regenxbio Inc 0.61%
CCXI ChemoCentryx Inc 0.60%
RLMD Relmada Therapeutics Inc 0.60%
BCEL Atreca Inc 0.60%
RUBY Rubius Therapeutics Inc 0.59%
RVMD REVOLUTION Medicines Inc 0.58%
KNSA Kiniksa Pharmaceuticals Ltd 0.58%
DTIL Precision BioSciences Inc 0.58%
VSTM Verastem Inc 0.57%
RCUS ARCUS BIOSCIEN 0.56%
OYST Oyster Point Pharma Inc 0.56%
PRVL Prevail Therapeutics Inc 0.55%
PHAT Phathom Pharmaceuticals Inc 0.54%
AVRO Avrobio Inc 0.54%
VIE Veolia Environnement SA 0.53%
FIXX Homology Medicines Inc 0.52%
AMRS Amyris Inc 0.51%
CALA Calithera Biosciences Inc 0.50%
CNST Constellation Pharmaceuticals Inc 0.50%
CUE Cue Biopharma Inc 0.50%
ORTX Orchard Therapeutics PLC 0.50%
QURE uniQure NV 0.49%
RETA Reata Pharmaceuticals Inc 0.47%
ADVM ADVERUM BIOT O 0.44%
APLT Applied Therapeutics Inc 0.42%
ALEC Alector 0.35%
TCDA Tricida Inc 0.33%
ODT Odonate Therapeutics Inc 0.29%
NXTC NextCure Inc 0.28%
CRBP Corbus Pharmaceuticals Holdings Inc 0.21%
AKBA Akebia Therapeutics Inc 0.17%
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.00%
Cash/Cash equivalents 0.00%

BBC - Top Stories


View All BBC News

BBC - Price/Volume Stats

Current price $42.63
Prev. close $41.99
Day low $41.75
Day high $42.63
52-week high $45.70
52-week low $22.92
Day Volume 13,087
Avg. volume 32,929
Dividend yield 0.00%

BBC - Recent Returns

1-mo 4.51%
3-mo -3.83%
6-mo 50.11%
1-year 56.27%
3-year 50.16%
5-year 34.69%
YTD 12.03%
2019 63.81%
2018 -18.29%
2017 56.12%
2016 -36.63%
2015 5.25%

BBC - Stock Chart


BBC - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

Most Popular Articles



7 Best ETFs for the NEXT Bull Market
Page generated in 1.8942 seconds.